Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Enimmune corporation

Market Cap 1.19B 37.49M 32.69M 30.27M 28.34M 53.15M 3.54B 53.47M 359M 139M 1.74B 141M 138M 6.05B P/E 2024
-11.3x
P/E 2025 -9.04x
Enterprise Value 1.13B 35.76M 31.18M 28.88M 27.04M 50.7M 3.37B 51.01M 343M 133M 1.66B 134M 131M 5.77B EV / Sales 2024
35.4x
EV / Sales 2025 29.7x
Free-Float
-
Yield 2024 *
-
Yield 2025 -
1 day+1.23%
1 week-4.91%
Current month-5.46%
1 month-11.56%
3 months-4.36%
6 months-19.95%
Current year-20.15%
1 week 16.2
Extreme 16.2
17.35
1 month 16.2
Extreme 16.2
18.85
Current year 16.1
Extreme 16.1
22.15
1 year 14.65
Extreme 14.65
23.9
3 years 14.65
Extreme 14.65
51.3
5 years 14.65
Extreme 14.65
75.3
10 years 14.49
Extreme 14.49
125
Manager TitleAgeSince
Chief Executive Officer - 07/01/2019
Chief Tech/Sci/R&D Officer - 21/07/2014
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Director/Board Member - 17/06/2020
Chairman - 07/01/2019
Director/Board Member - 02/01/2014
Change 5-day change 1-year change 3-year change Capi.($)
+1.23%-4.91%+3.46%-67.23% 37.49M
+1.44%-1.25%+64.25%+114.23% 55.19B
+4.60%+3.02%+57.38%+48.98% 45.75B
-1.44%+0.39%-14.68%-17.33% 22.98B
-2.69%-2.10%-6.70%+374.02% 20.76B
+3.22%-0.84%+27.88%-20.46% 16.26B
+0.58%+1.08%+18.85%-37.32% 15.42B
-1.01%-2.30%+28.59%+174.08% 13.05B
+4.95%+11.70%+125.78%+252.19% 12.45B
+3.07%+0.14%+29.05% - 12.37B
Average +1.40%+1.52%+33.39%+91.24% 21.43B
Weighted average by Cap. +1.63%+1.47%+40.77%+101.11%

Financials

2024 2025
Net sales 39.92M 1.26M 1.1M 1.02M 953K 1.79M 119M 1.8M 12.08M 4.68M 58.57M 4.73M 4.63M 203M 48.19M 1.52M 1.33M 1.23M 1.15M 2.16M 144M 2.17M 14.59M 5.65M 70.72M 5.72M 5.59M 246M
Net income -158M -4.98M -4.34M -4.02M -3.76M -7.06M -470M -7.1M -47.68M -18.48M -231M -18.68M -18.28M -803M -164M -5.19M -4.53M -4.19M -3.93M -7.36M -490M -7.41M -49.74M -19.28M -241M -19.49M -19.07M -837M
Net Debt -382M -12.07M -10.52M -9.75M -9.12M -17.11M -1.14B -17.21M -116M -44.81M -561M -45.3M -44.33M -1.95B -54.59M -1.72M -1.5M -1.39M -1.3M -2.45M -163M -2.46M -16.52M -6.4M -80.11M -6.47M -6.34M -278M
Logo Enimmune corporation
ENIMMUNE CORP. is a Taiwan-based biotechnology new drug company mainly engaged in the development, produce and distribution of new drugs. The Company's new drug products include biological agents, monoclonal antibodies, vaccines, and small molecule drugs. The Company mainly conducts drug testing business, biotechnology service business, international trade business, western medicine wholesale and retail business. The product is Tuberculin PPD.
Employees
-
Date Price Change Volume
18/06/26 16.45 NT$ +1.23% 39,419
17/06/26 16.25 NT$ -2.99% 26,203
16/06/26 16.75 NT$ -3.18% 118,674
15/06/26 17.30 NT$ 0.00% 17,595
12/06/26 17.30 NT$ -0.29% 41,560
  1. Stock Market
  2. Stocks
  3. 6564 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!